Multi-Campus Effort Aims to Regenerate Arthritic Joints

Osteoarthritis, a painful degenerative disease that affects 32.5 million Americans, slowly degrades buffering cartilage until joints grind together bone-on-bone. With no existing effective regenerative therapy, treatments are limited to anti-inflammatory injections and, ultimately, expensive joint […]

No Picture

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

– Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) –– Data presented in a platform session at the Annual Meeting of the American Academy […]